At a glance
- Originator Shionogi
- Class Antiarrhythmics; Antihypertensives
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Hypertension; Myocardial infarction
Most Recent Events
- 29 Jun 2000 Discontinued-Clinical for Arrhythmias in Japan (Unknown route)
- 29 Jun 2000 Discontinued-Clinical for Myocardial infarction in Japan (Unknown route)
- 26 Jun 2000 Discontinued-II for Hypertension in Japan (Unknown route)